British scientists are working on a method of monitoring conditions inside cancerous tumours using nanosensors.
The team is led by Dr Colin Campbell of Edinburgh University, UK. They developed model tumours of human cancer cells that create similar conditions to real tumours. Using these models they tested laser-activated nanosensors, to determine how well the sensors could monitor changes in tumours under different radiotherapy dosages.
The sensors showed, as the scientists predicted, that tumours respond differently to different radiotherapy treatment schedules. Specifically, they found that two doses of 6 Gy of radiation attacked the tumour cells more effectively than a single dose of 12 Gy or three doses of four Gy. It did so by reducing the level of acidity inside tumours, they add.
Dr Campbell and the team hope that this insight could lead to improved radiotherapy for patients, by designing individual treatment plans to maximise the impact of radiotherapy and minimise side effects.
Details of the study are published today (15 June) in The Royal Society of Chemistry.
Dr Campbell said: "This exciting research could give us a greater understanding of how radiotherapy affects tumours. By working so closely with our colleagues at the Edinburgh Cancer Centre, we have an opportunity to translate our findings into clinical practice."
The team say their nanosensors are about 130 nanometres in diameter. Made from organic reporter molecules, they are taken up by cells, and are not toxic to human cells. Once absorbed, the nanosensors are monitored by surface-enhanced Raman spectroscopy, allowing "non-invasive real-time imaging of cells."
Campbell, C. et al. The Royal Society of Chemistry 15 June 2016

Leave a Reply